Cyberonics Inc: (NASD: CYBX)

$49.51

0.39 (0.79%)

Volume 224,605

May 21 04:00 PM ET

Zacks Rank: 3-Hold

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		48.90 - 49.69
	
		52wk Low - High
		36.82 - 56.73
	
		Previous Close
		49.12
	
		Avg. Volume
		361,480
	
		Industry
		MED INSTRUMENTS
	
		Market Cap
		1.36 B
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		0.70
	
		PE (Forward)
		25.50
	
		Current Year Est.
		1.93
	
		Quarterly Earnings ESP 
		NA
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		3
Hold

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Outperform
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		114 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of 04/10/2013

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            25.50
                        
                            PEG Ratio
                            1.36
                        
                            Current Year Est.
                            1.93
                        
                            Current Quarter Estimate
                            0.42
                        
                            Most Accurate Estimate
                            NA
                        
                            Earnings ESP 
                            NA
                        
                            Next Earnings Report Date
                            06-05-2013
                        
                            EPS Last Year
                            1.67
                        
                            Expected Earnings Growth
                            18.75%
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Cyberonics, Inc. was founded to design, develop and market medical devices for the treatment of epilepsy and other debilitating neurological disorders using a therapy, vagus nerve stimulation.  The company's initial target market is epilepsy, the world's second most prevalent neurological disorder, which is characterized by seizures.  Vagus nerve stimulation with the Cyberonics NCP System was approved for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents with medically refractory partial onset seizures.  (PRESS RELEASE)   
Full CYBX Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
CYBX Chart  by YCharts

Earnings Estimates

	Current Qtr (04/2013)	Next Qtr (07/2013)	Current Year (04/2013)	Next Year (04/2014)
Average Estimate	0.42	0.45	1.70	1.93
Number of Estimates	5	5	6	5
Low Estimate	0.40	0.43	1.68	1.83
High Estimate	0.45	0.46	1.73	NA
Year Ago EPS	0.38	0.38	1.27	1.70
EPS Growth	11.58%	17.89%	33.99%	13.18%

More CYBX Estimates

Average Earnings Estimates for CYBX

EPS Growth for CYBX

Industry Analysis

Name	Symbol	Previous Close
CYBERONICS INC	CYBX	49.12
NATUS MEDICAL	BABY	14.24
CRYOLIFE INC	CRY	6.42
DELCATH SYS INC	DCTH	0.44
GLOBUS MEDICAL	GMED	15.90
HEARTWARE INTL	HTWR	97.45
INTUITIVE SURG	ISRG	479.42
MELA SCIENCES	MELA	1.08
OXYSURE SYSTEMS	OXYS	0.86
PACIFIC BIOSCI	PACB	2.50

Sector:Medical>> Industry:MED INSTRUMENTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Earnings Beat for ABAX, Sluggish Overall

Apr 26, 2013

PerkinElmer Misses Earnings and Rev Est

Apr 26, 2013

BSX Beats Y/Y Earnings, Guides Low

Apr 25, 2013

OCR Beats on Earnings Est; Misses Rev

Apr 25, 2013

Varian Beats Earnings and Rev Est

Apr 25, 2013

TMO's Earnings Beat, LIFE Buyout on Track

Apr 24, 2013

AmSurg's Rev and Earnings In Line

Apr 24, 2013

Illumina Beats on Earnings, Revenue

Apr 23, 2013

More CYBX Zacks Commentary

Financials

EPS TTM	1.67
Sales	219
Net Income	45
Price/Earnings	29.41
Price/Book	6.07
Price/Cash Flow	34.41
Price/Sales	5.57

More CYBX Financials

News

Cyberonics Makes a Move: Up 1.7% - Financial News Network Online - Market Movers

May 17, 2013

Stock Investors Bid Up Shares of Cyberonics, Up 1.6% - Financial News Network Online - Market Movers

May 13, 2013

The Global Deep Brain Stimulator Market to Grow At A CAGR Of 16.99 Percent over the Period 2012-2016 - M2

May 13, 2013

Neuromodulation Market Research Report Forecasts to 2017 - Neuromodulation emerging as one of the fastest growing segments of the medical device market - M2

May 10, 2013

Stock Investors Bid Up Shares of Cyberonics, Up 3.1% - Financial News Network Online - Market Movers

May 9, 2013

Cyberonics Inc.Corporate Event Announcement Notice - Wall Street Horizon

May 8, 2013

Cyberonics Inc.Corporate Event Announcement Notice - Wall Street Horizon

May 7, 2013

Cyberonics To Report Fourth Quarter And Fiscal Year 2013 Results And Host Webcast And Conference Call On June 5, 2013 - Pr Newswire

May 7, 2013

See All News Stories on CYBX

Broker Recommendations

Current ABR	1.70
ABR (Last Week)	1.70
# of recs in ABR	10
Average Target Price	55.56
Industry Rank by ABR	114 out of 265
Rank in Industry	11 out of 52

More CYBX Broker Recommendations

Day Low - High	48.90 - 49.69
52wk Low - High	36.82 - 56.73
Previous Close	49.12
Avg. Volume	361,480
Industry	MED INSTRUMENTS
Market Cap	1.36 B
Div - Yield	0.00 - 0.00
Beta	0.70
PE (Forward)	25.50
Current Year Est.	1.93
Quarterly Earnings ESP	NA

PE (Forward)	25.50
PEG Ratio	1.36
Current Year Est.	1.93
Current Quarter Estimate	0.42
Most Accurate Estimate	NA
Earnings ESP	NA
Next Earnings Report Date	06-05-2013
EPS Last Year	1.67
Expected Earnings Growth	18.75%

Username: Password:

Remember me [?]

Cyberonics Inc: (NASD: CYBX)

$49.51

0.39 (0.79%)

Volume 224,605

May 21 04:00 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED INSTRUMENTS

Zacks Commentary

Financials

News

Broker Recommendations